Source: European Medicines Agency (EU) Revision Year: 2025 Publisher: Pfizer Ireland Pharmaceuticals Unlimited Company, Operations Support Group, Ringaskiddy, County Cork, Ireland
Zinforo 600 mg powder for concentrate for solution for infusion.
| Pharmaceutical Form |
|---|
|
Powder for concentrate for solution for infusion (powder for concentrate). A pale yellowish-white to light yellow powder. |
Each vial contains ceftaroline fosamil acetic acid solvate monohydrate equivalent to 600 mg ceftaroline fosamil.
After reconstitution, 1 ml of the solution contains 30 mg of ceftaroline fosamil.
For the full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Ceftaroline is a cephalosporin antibacterial with in vitro activity against Gram-positive and -negative bacteria. The bactericidal action of ceftaroline is mediated through binding to essential penicillin-binding proteins (PBPs). Biochemical studies have shown that ceftaroline has high affinity for PBP2a of methicillin-resistant Staphylococcus aureus (MRSA) and PBP2x of penicillin non-susceptible Streptococcus pneumoniae (PNSP). As a result, minimum inhibitory concentrations (MICs) of ceftaroline against a proportion of these organisms tested fall into the susceptible range. |
| List of Excipients |
|---|
|
Arginine |
20 ml glass vial (Type 1) closed with a rubber (halobutyl) stopper and aluminium seal with flip-off cap.
The medicinal product is supplied in packs of 10 vials.
Pfizer Ireland Pharmaceuticals Unlimited Company, Operations Support Group, Ringaskiddy, County Cork, Ireland
EU/1/12/785/001
Date of first authorisation: 23 August 2012
Date of the latest renewal: 24 April 2017
| Drug | Countries | |
|---|---|---|
| ZINFORO | Austria, Brazil, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.